Print

Print


John and all,

You a valid point John!  Let there be no mistake in where corporate
priorities lie........be it a defense contractor or a corporation dedicated
to the research and development of pharmaceuticals; They both are created
equal with a common goal.......to make as much money as possible!  The
intent of the pharmaceutical corporations is not to find cures........that
would eventually stop their "money-train".  If "treating" a disease is more
profitable than effecting its cure,  well, let's just say that they would
have us popping pills forever!  This is why we must have public funding for
Parkinsons' research.  The corrupt and money motivated pharmaceutical
companies will do absolutely everything (including murder if they can get
away with it) in their power in order to protect their billions in monthly
revenues.

If anyone thinks that I am being a little ruff on these companies, consider
this:  Napalm has been used for many decades in many wars to "clear the
land" as well as burn alive all the inhabitants.........Thanks DuPont!
Sinemet has helped millions.........Thanks
DuPont!.........conscionable?.........I rest my case.

Jay Henkelman
49/39/30

-----Original Message-----
From: John Cottingham <[log in to unmask]>
To: [log in to unmask] <[log in to unmask]>
Date: Saturday, February 13, 1999 6:03 PM
Subject: Re: Cell Genesys Article


>>Cell Genesys' current business strategy is to seek a licensing partner for
>>its Parkinson's disease gene therapy program.
>
>Treating Parkinson's is big business and like it or not, the major
>Parkinson's organizations are mostly funded by the pharmaceutical industry.
>
>If a nose spray with the AAV vectors could cure Parkinson's, isn't it
>conceivable that a drug company would buy the technology and rights and
>"study" it to death quietly. Since they would own the rights, they could
>keep it off the market and it would never get to the FDA.
>
>The drug industry fears a cure for Parkinson's. Two to three thousands of
>dollars per year times a million patients would be a big loss. Startup
>companies like Genesys don't have the funds to take this idea through
trials.
>
>
>What are the possible solutions?
>
>
>
>
>[log in to unmask]   Search the parkinsn archive online at:
>                 http://james.parkinsons.org.uk
>                Catch the Parkinsn List messages on line at:
>               http://www.ionet.net/~jcott/homepage/archive/patp.html
>             *NEW*Click the page ads and use the new search tools*NEW*
>John Cottingham